Approach to the Immunocompromised Host with Infection in the Intensive Care Unit

Infectious Disease Clinics of North America

Volumn 23, Issue 3, 2009, Pages 535-556

  Linden, Peter K ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

HIV; Immunocompromised; Immunosuppression; Neutropenia; Nosocomial infection; Opportunistic infection; Organ transplantation

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN; AMPICILLIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CARBAPENEM; CASPOFUNGIN; CEPHALOSPORIN; CORTICOSTEROID; COTRIMOXAZOLE; DAPTOMYCIN; DROTRECOGIN; FLUCONAZOLE; GANCICLOVIR; LINEZOLID; POLYENE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAPAMYCIN; TIGECYCLINE; VALGANCICLOVIR; VANCOMYCIN; VORICONAZOLE;

ACUTE LUNG INJURY; ASPERGILLOSIS; BACTERIAL COLONIZATION; BONE MARROW TRANSPLANTATION; CANDIDEMIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CRITICAL ILLNESS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG CHOICE; EARLY INTERVENTION; EVIDENCE BASED MEDICINE; FEBRILE NEUTROPENIA; FEVER; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRANULOCYTOPENIA; HEALTH CARE COST; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; LENGTH OF STAY; LISTERIOSIS; LUNG INFILTRATE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIAL IDENTIFICATION; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; NEUTROPENIA; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PSEUDOMEMBRANOUS COLITIS; RESPIRATORY FAILURE; RESUSCITATION; REVIEW; SEPSIS; STEM CELL TRANSPLANTATION; STREPTOCOCCUS INFECTION; THORAX RADIOGRAPHY;

BONE MARROW TRANSPLANTATION; CRITICAL ILLNESS; CROSS INFECTION; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; NEOPLASMS; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION;

EID: 68049120591     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2009.04.014     Document Type: Review

References (67)

1. Rosen M.J., and Narasimhan M. Critical care of immunocompromised patients: human immunodeficiency virus. Crit Care Med 34 Suppl (2006) S245-S250
2. Powell K., Davis J.L., Morris A.M., et al. Survival for patients with HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest 135 (2009) 11-17
3. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
4. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
5. Rivers E., Nguyen B., Havstad S., et al. Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368-1377
6. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342 (2000) 1301-1308
7. Shorr A.F., Sulsa G.M., and O'Grady N.P. Pulmonary infiltrates in the non-HIV infected immunocompromised patient. Etiologies, diagnostic strategies and outcomes. Chest 125 (2004) 260-271
8. Shorr A.F., Moores L.K., Edenfield W.J., et al. Mechanical ventilation in hematopoietic stem cell transplantation: can we effectively predict outcomes?. Chest 116 (1999) 1012-1018
9. Hilbert G., Gruson D., Varges F., et al. Non-invasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever and acute respiratory failure. N Engl J Med 344 (2001) 481-487
10. Duran F.G., Piqueras B., Romero M., et al. Pulmonary complications following orthotopic liver transplant. Transpl Int 11 Suppl 1 (1998) S255-S259
11. Kotloff R.M., Ahya V.N., and Crawford S.W. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 170 (2004) 22-48
12. Heussel C.P., Kauczor H.U., Heussel G., et al. Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. AJR Am J Roentgenol 169 (1997) 1347-1353
13. Barloon J.T., Galvin J.R., Mori M., et al. High-resolution ultrafast chest CT in the management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms. Chest 99 (1991) 928-933
14. Jain P., Sandur S., Meli Y., et al. Role of fiber optic bronchoscopy in immunocompromised patients with lung infiltrates. Chest 125 (2004) 712-722
15. Paterson D.L., and Singh N. Invasive aspergillosis in transplant recipients. Medicine 78 (1999) 128-138
16. Paterson T.F., Kirkpatrick W.R., White M., et al. Invasive aspergillosis: disease spectrum, treatment practices, and outcomes. Medicine 79 (2000) 250-260
17. Rano A., Agusti C., Jimenez P., et al. Pulmonary infiltrates in non-HIV immunocompromised patients; a diagnostic approach using non invasive and bronchoscopic procedures. Thorax 56 (2001) 379-387
18. White D.A., Wong P.W., and Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 161 (2002) 723-729
19. Weill D., McGriffin D.C., Zorn G.L., et al. The utility of open lung biopsy following lung transplantation. J Heart Lung Transplant 19 (2000) 852-857
20. Feins R.H. The role of thoracoscopy in the AIDS/immunocompromised patient. Ann Thorac Surg 56 (1993) 649-650
21. Cunha B.A. Central nervous system infections in the compromised host: a diagnostic approach. Infect Dis Clin North Am 15 (2001) 567-590
22. Coley S.C., Jagar H.R., Szydio R.M., et al. CT and MRI manifestations of central nervous system infection following allogeneic bone marrow transplantation. Clin Radiol 54 (1999) 390-397
23. Foerster B.R., Thurnher M.M., Malani P.N., et al. Intracranial infections: clinical and imaging characteristics. Acta Radiol 48 (2007) 875-893
24. Mylonakis E., Hohmann E.L., and Calderwood S.B. Central nervous system infection with Listeria monocytogenes; 33 years of experience from a general hospital and review of 776 cases from the literature. Medicine 77 (1998) 313-336
25. Paul M., Soares-Weiser K., and Leibovici L. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 326 (2003) 1111-1126
26. Paul M., Yahav D., Fraser A., et al. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 57 (2006) 176-189
27. Raad I., Hanna H., Boktour M., et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 38 (2004) 1119-1127
28. Raad I., Hanna H., Boktour M., et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 38 (2004) 1119-1127
29. Alessa B., Tefferi A., Hoagland H.C., et al. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 67 (1992) 117-122
30. Paz H.L., Crilley P., Weinar M., et al. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest 104 (1993) 527-531
31. Afessa T., Tefferi A., Dunn W.F., et al. Intensive care unit support and acute physiology and chronic health evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med 31 (2003) 1715-1721
32. Soubani A.O. Critical care considerations of hematopoietic stem cell transplantation. Crit Care Med 34 Suppl (2006) S251-S267
33. Colin B.A., Leather H.L., Wingard J.R., et al. Evolution, incidence and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 33 (2001) 947-953
34. Mossad S.B., Longworth D.L., Goormastic M., et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 18 (1996) 265-271
35. Bilgrami S., Feingold J.M., Dorsky D., et al. Streptococcus viridans, bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 21 (1998) 591-595
36. Bochud P.Y., Calandra T., and Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 97 (1994) 256-264
37. Marr K.A., Siedel K., Slavin M.A., et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long term follow-up of a randomized, placebo-controlled trial. Blood 96 (2000) 2055-2061
38. Bodey G.P., Mardani M., Hanna H.A., et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med 112 (2002) 380-385
39. Marr K.A., Boeckh M., Carter R.A., et al. Combination therapy for invasive aspergillosis. Clin Infect Dis 39 (2004) 797-802
40. Fishman J.A. Infection in solid organ transplant recipients. N Engl J Med 357 (2007) 2601-2614
41. Avery R.K. Infections after lung transplantation. Semin Respir Crit Care Med 27 (2006) 544-551
42. Hadjiliadis D. Special considerations for patients undergoing lung transplantation for cystic fibrosis. Chest 131 (2007) 1224-1231
43. Freeman R.B., Giatras I., Falagas M.E., et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 68 (1999) 1107-1111
44. Rubin R.H. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA 261 (1989) 3607-3609
45. Snydman D.R. The case for cytomegalovirus prophylaxis in solid organ transplantation. Rev Med Virol 16 (2006) 289-295
46. Kalil A.C., Levitsky J., Lyden E., et al. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 143 (2005) 870-880
47. Hodson E.M., Jones C.A., Webster A.C., et al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid organ transplants: a systematic review of randomised controlled trials. Lancet 365 (2005) 2105-2115
48. Falagas M.E., Snydman D.R., Griffith J., et al. Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group. Clin Infect Dis 25 (1997) 314-317
49. Bonatti H., Tab relli W., Ruttmann E., et al. Impact of cytomegalovirus match on survival after cardiac and lung transplantation. Am Surg 70 (2004) 710-714
50. Mutimer D., Mirza D., shaw J., et al. Enhanced cytomegalovirus viral replication associated with septic bacterial complications in liver transplant recipients. Transplantation 63 (1997) 1411-1415
51. Humar A., St Louis P., Mazzulli T., et al. Elevated serum cytokines are assoicated with cytomegalovirus infection and disease in bone marrow transplant recipients. J Infect Dis 179 (1999) 484-488
52. Wolff A.J., and O'Donnell A.E. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest 120 (2001) 1888-1893
53. Allen S.H., Brennan P., Nelson M., et al. Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era. Postgrad Med J 79 (2003) 691-694
54. Wislez M., Bergot E., Antoine M., et al. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 164 (2001) 847-851
55. Narita M., Ashkin D., Hollender E.S., et al. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158 (1998) 157-161
56. Manez R., Kusne S., Linden P., et al. Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation 57 (1994) 149-151
57. Swinnen L.J. Organ transplant related lymphoma. Curr Treat Options Oncol 2 (2001) 301-308
58. Srividyalakshmi S., and Baumann M.A. Reverse isolation for neutropenic patients. Community Oncol 5 (2008) 628-632
59. Hahn T., Cummings K.M., Michalek A.M., et al. Efficacy of high efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infect Control Hosp Epidemiol 23 (2002) 525-531
60. Fischl M.A., Uttamchandani R., Dalkos G.L., et al. An outbreak of tuberculosis caused by multiple drug resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 117 (1992) 177-183
61. Herrero I.A., Issa N.C., and Patel R. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med 346 (2002) 867-869
62. Poque J.M., Paterson D.L., Pasculle A.W., et al. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 28 (2007) 1382-1388
63. Schaier M., Wendt C., Zaier M., et al. Clostridium difficile diarrhea in the immunosuppressed patient. Update on prevention and therapy. Nephrol Dial Transplant 19 (2004) 2432-2436
64. Trifilio S., Singhal S., Williams S., et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 40 (2007) 451-456
65. Siwek G.T., Dodgson K.J., de Magalhaes-Silverman M., et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 39 (2004) 584-587
66. Limaye A.P., Raghu G., Koelle D.M., et al. High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. J Infect Dis 185 (2002) 20-27
67. Martin B.K., Ricks M.O., Forman M.S., et al. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis. Clin Infect Dis 44 (2007) 1001-1008